@emjreviews.comIn our latest Editor’s Pick, EMJ Editor Sean Boyle highlights a standout review exploring the impact of factors such as fatigue and medication burden, and why HCPs need to look beyond the data alone.
Learn more: www.emjreviews.com/neurology/ar...
@emspofficial.bsky.socialOnly 48% of people with MS are in work across the European countries that report data. MS is usually diagnosed between 20 and 40 — peak career years.
Our CEO @lili_ @eumsplatform speaks on brain health and employment today at #IFDM2026 in Edinburgh. #MultipleSclerosis
@kadavercosplay.bsky.socialfeel a lot better having slept. Still a little nauseous but I'm like that all the time and I'm not as dizzy. I'm going to rest the week and try to let this stuff get out of my system. Just another fun night in the E.R. 😑
#multiplesclerosis #epilepsy #sideeffects #medicine #hospital #blooddraw #help
@wheelieoutthere.bsky.socialTDo you need a computer? The National MS Society, in partnership with Human-I-T, can help!
To get more information or get signed up, contact an MS Navigator by calling 1-800-344-4867 or go to www.nationalmssociety.org/resources/ge...
@kevjbyrne.bsky.socialAmazon, You are making it painfully impossible for a nonprofit to spread their message and help so many people. Why? #NeverStopNeverQuitForThem #MultipleSclerosis #WorldSuicidePreventionDay #VeteranSuicidePrevention #VetsReachOut
@kevjbyrne.bsky.socialKicking up the tunes, with shoutouts to all of the teams, because Bike MS Is Coming! #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK
@msnewstoday.bsky.socialGet the scoop: https://bit.ly/4hlMKSW
Four molecules may be used as biomarkers for response to MSC-NP, an experimental stem cell therapy for progressive MS, a study found.
@neurologyadvisor.bsky.socialReduced daytime #PhysicalActivity, particularly during midday hours, may serve as an objective marker of specific neurologic deficits and overall disease severity in patients with progressive #MultipleSclerosis.
@msnewstoday.bsky.socialTake a closer look: https://bit.ly/4rs479w
European Union regulators recommended that the infusion therapy Ocrevus be approved to treat relapsing MS in patients ages 10 and older.
@ijmsc.bsky.socialTelerehab isn't a replacement for in-person MS physical therapy: It's a complement. Study of 111 patients at UCSF: hybrid care could improve access, attendance, and treatment completion for people with demyelinating disease.
doi.org/10.7224/1537...
#MultipleSclerosis #telerehab
@breakingnews06.bsky.socialChristina Applegate Shares Pic of "Weird Spot" on Cheek Amid MS Battle #ChristinaApplegate #MultipleSclerosis #MSAwareness #SelfCare #HealthJourney
@techsagererc.bsky.socialDid you know that MSafe is helping older adults with #MultipleSclerosis assess and monitor their fall risk? Learn how this user-friendly app supports self-assessment and awareness through simple questions and short assessments. #MS
🔗 Read the full open-access article: https://ow.ly/3Yhs50Yv5Z5
@dhsc-answers.bsky.socialA question on #MultipleSclerosis #HealthServices tabled by Jim Shannon on 07-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-07/27453
@dhsc-answers.bsky.socialA question on #MultipleSclerosis #HealthServices tabled by Jim Shannon on 07-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-07/27454
@dhsc-answers.bsky.socialA question on #MultipleSclerosis #HealthServices tabled by Jim Shannon on 07-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-07/27455
@dhsc-answers.bsky.socialA question on #MultipleSclerosis #HealthServices tabled by Jim Shannon on 09-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-09/28315
@dhsc-answers.bsky.socialA question on #MultipleSclerosis #HealthServices tabled by Jim Shannon on 09-09-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-09-09/28316
@chemcenterbio.bsky.socialThe Most Promising MS Peptide to Date?
Groundbreaking P21 peptide science demonstrates massive neurogenesis and myelin protection in laboratory study animals only. #MSWarrior #MSResearch #Neuroprotection #Remyelination #MultipleSclerosis
@gregoryai.bsky.socialNew clinical trial
Evaluation of an Online, On Demand Multimodal Wellness Program to Reduce Fatigue and Improve Quality of Life in Progressive Multiple Sclerosis: A Randomized Waitlist Controlled Trial (DEW Study)
@gregoryai.bsky.socialNew clinical trial
ASSOCIATION BETWEEN PERIPHERAL IMMUNE BIOMARKERS AND FUNCTIONAL PERFORMANCE IN PATIENTS WITH MULTIPLE SCLEROSIS